Original: Abramson et al., Nature 2024
DOI: 10.1038/s41586-024-07487-w

Abstract

AlphaFold 3 is a biomolecular structure prediction model developed by DeepMind and Isomorphic Labs, using diffusion-based architecture updates to uniformly predict complex structures including proteins, nucleic acids, small molecules, ions, and modified residues. On the PoseBusters benchmark test, the model significantly outperforms traditional molecular docking tools and similar deep learning methods in protein-ligand interaction prediction.

1. Research Background

1.1 Progress in Protein Structure Prediction

The release of AlphaFold 2 marked a major breakthrough in protein structure prediction, achieving near-experimental accuracy for single-chain protein structure prediction through deep learning methods. Subsequently, AlphaFold-Multimer extended prediction capabilities to protein-protein complexes.

1.2 Challenges in Multi-type Biomolecular Prediction

Although AlphaFold 2 achieved significant success in protein structure prediction, biological systems contain various types of molecular interactions, including protein-nucleic acid, protein-small molecule ligand, ion, and modified residue interactions. These interactions are crucial for understanding cellular functions and drug design.

1.3 Limitations of Existing Methods

Traditional molecular docking tools (such as AutoDock Vina) rely on experimentally determined protein structures as input and cannot truly achieve de novo prediction. Specialized deep learning methods, while performing well on specific tasks, cannot handle complexes containing multiple molecular types.

2. Technical Architecture Overview

AlphaFold 3 makes substantial architectural updates based on the overall workflow of AlphaFold 2, mainly including three core components: Input Embedding Module, Pairformer Processing Module, and Diffusion Generation Module.

2.1 Input and Embedding

The model accepts polymer sequences (proteins, DNA, RNA), small molecule SMILES representations, covalent bond information, and optional template structures as input. The input embedder converts various chemical entities into unified token representations.

2.2 Pairformer Module

Pairformer replaces Evoformer in AlphaFold 2 as the core processing unit of the model. This module only operates on pair representations and single representations, greatly simplifying Multiple Sequence Alignment (MSA) processing:

2.3 Diffusion Module

The diffusion module is the most significant architectural innovation of AlphaFold 3, directly replacing the structure module of AlphaFold 2. This module operates directly on raw atomic coordinates rather than amino acid-specific frameworks and side chain torsion angles.

The diffusion process is trained at different noise levels:

2.4 Confidence Prediction

AlphaFold 3 develops a diffusion rollout procedure: using larger step sizes for mini rollout to generate predicted structures during training, calculating performance metrics accordingly and training confidence heads. Confidence heads predict based on pair representations:

3. Performance Evaluation

3.1 Protein-Ligand Interactions

On the PoseBusters benchmark dataset (428 protein-ligand structures), AlphaFold 3 significantly outperforms with pocket-aligned ligand RMSD < 2Å as the success criterion:

Notably, AlphaFold 3 only uses protein sequences and ligand SMILES as input, while traditional docking tools rely on experimentally determined protein structures.

3.2 Protein-Nucleic Acid Interactions

In protein-nucleic acid complex prediction, AlphaFold 3 outperforms the specialized predictor RoseTTAFold2NA (P < 0.001). The model can predict large protein-nucleic acid complexes containing thousands of residues.

3.3 Covalent Modification Prediction

The model also performs well in predicting covalent modifications (including bonded ligands, glycosylation, modified protein residues, and nucleic acid bases). Single-residue glycosylation success rates are comparable to bonded ligands; multi-residue glycosylation success rates are slightly lower (42.1%, n=131).

3.4 Protein-Protein Interactions

Compared to AlphaFold-Multimer v2.3, AlphaFold 3 achieves significant improvement in protein-protein interface prediction (P = 1.81 × 10⁻¹⁸). Antibody-antigen interface prediction improvements are particularly notable (P = 6.54 × 10⁻⁵).

3.5 Confidence Calibration

AlphaFold 3's confidence metrics (ipTM, pLDDT, PAE) show good calibration relationships with prediction accuracy. High ipTM scores correspond to high interface accuracy, and high pLDDT corresponds to high LDDT_to_polymer scores.

4. Model Limitations

4.1 Stereochemistry Issues

Model outputs have two main types of chiral violations:

  1. Chiral center non-conservation: Chiral violation rate of 4.4% in PoseBusters benchmark
  2. Atom clashes: Severe violations of physically reasonable atomic position overlaps observed in some predictions

4.2 Hallucination Issues

The shift from non-generative models to diffusion generative models introduces new technical challenges: generating false structural order (hallucinations) in disordered regions. AlphaFold 3 uses cross-distillation methods to mitigate this issue.

4.3 Dynamic Behavior Prediction

Like all PDB-trained models, AlphaFold 3 predicts static conformations observed in crystal structures rather than dynamic behaviors of biomolecules in solution. The model cannot capture conformational changes, folding processes, and thermal fluctuations.

4.4 Dependence on MSA Depth

AlphaFold 3's dependence on Multiple Sequence Alignment (MSA) depth is similar to AlphaFold-Multimer v2.3: proteins with shallower MSA have lower prediction accuracy.

5. Discussion and Conclusion

5.1 Advantages and Trade-offs of Unified Framework

AlphaFold 3 demonstrates the possibility of achieving high-precision modeling across biomolecular space within a single deep learning framework. The unified approach simplifies workflows and reduces compatibility issues between specialized tools. However, this unification may also mean not achieving optimal performance of specialized models on specific tasks.

5.2 Characteristics of Diffusion Models

The adoption of diffusion architecture brings advantages of generative modeling: ability to produce multi-solution distributions and maintain clear definitions in local structures. However, this also introduces hallucination risks and training complexity.

5.3 Application Prospects

For drug discovery applications, AlphaFold 3's prediction capabilities provide valuable tools for early target assessment and compound screening, but final drug design decisions still require careful consideration of model confidence metrics and known limitations.

Future Improvement Directions

  • Improve diffusion sampling strategies to reduce hallucinations
  • Enhance enforcement of chiral constraints
  • Integrate time dimension to model dynamic behaviors
  • Expand training data to cover broader chemical space

Important Note: Unlike AlphaFold 2, AlphaFold 3's commercial use license is restricted. Users must comply with corresponding license agreements in commercial applications.

References:
[1] Abramson, J., Adler, J., Dunger, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493–500 (2024). https://doi.org/10.1038/s41586-024-07487-w

← Back to Blog